ABCL
Price
$13.73
Change
-$0.18 (-1.29%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
4.51B
39 days until earnings call
Intraday BUY SELL Signals
CURX
Price
$4.92
Change
-$0.06 (-1.20%)
Updated
Oct 2, 01:09 PM (EDT)
Capitalization
7.9M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs CURX

ABCL vs CURX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. CURX commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CURX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ABCLCURX
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ABCL: $13.91 vs. CURX: $4.98)
Brand notoriety: ABCL and CURX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 117% vs. CURX: 58%
Market capitalization -- ABCL: $4.51B vs. CURX: $7.9M
ABCL [@Biotechnology] is valued at $4.51B. CURX’s [@Biotechnology] market capitalization is $7.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green while CURX’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CURX’s FA Score: 1 green, 4 red.
According to our system of comparison, CURX is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while CURX’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • CURX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than CURX.

Price Growth

ABCL (@Biotechnology) experienced а +9.96% price change this week, while CURX (@Biotechnology) price change was +15.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABCL
Daily Signal:
Gain/Loss:
CURX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JYD0.890.11
+13.59%
Jayud Global Logistics Limited
ATO156.38-0.06
-0.04%
Atmos Energy Corp
BWMN42.59-0.05
-0.12%
Bowman Consulting Group Ltd
BATRK52.25-0.69
-1.30%
Atlanta Braves Holdings
RYDE0.68-0.03
-4.06%
Ryde Group Ltd

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-4.66%
RXRX - ABCL
59%
Loosely correlated
-1.45%
ABSI - ABCL
56%
Loosely correlated
-0.19%
VCYT - ABCL
56%
Loosely correlated
-4.02%
CRSP - ABCL
54%
Loosely correlated
+0.22%
EDIT - ABCL
51%
Loosely correlated
-1.95%
More

CURX and

Correlation & Price change

A.I.dvisor tells us that CURX and ICU have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURX and ICU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURX
1D Price
Change %
CURX100%
-1.34%
ICU - CURX
30%
Poorly correlated
-4.82%
CSBR - CURX
30%
Poorly correlated
-0.50%
NVAX - CURX
29%
Poorly correlated
-1.94%
ABCL - CURX
26%
Poorly correlated
-4.66%
VCEL - CURX
25%
Poorly correlated
-1.74%
More